Concepedia

Mark D. Tricklebank

MD

4

Publications

143

Citations

4

H-Index

1987

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Mark D. Tricklebank is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and neuropharmacology.

Top concepts

Publications per year

1987–1994

4

Publications

4

A role for receptors of N-methyl-D-aspartic acid in the discriminative stimulus properties of phencyclidine

Mark D. Tricklebank, Lakhbir Singh, Ryszard J. Oles et al. · European Journal of Pharmacology · 1987 · 70 citations

, , +9

In vivo labelling of the NMDA receptor channel complex by [3H]MK-801

Gary Price, Randy G. Ahier, Derek N. Middlemiss et al. · European Journal of Pharmacology · 1988 · 44 citations

, , +8

Lack of effect of flumazenil and CGS 8216 on the anxiolytic-like properties of loreclezole

Gerard R. Dawson, Rachel Curnow, Peter J. Bayley et al. · European Journal of Pharmacology · 1994 · 17 citations

, , +4

The potassium channel activator, BRL 34915, antagonises a behavioural response to the muscarinic receptor agonist, pilocarpine

Mark D. Tricklebank, Gail Flockhart, Stephen B. Freedman · European Journal of Pharmacology · 1988 · 12 citations

, , +13

Rows per page

1–4 of 4